Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001640334-25-000146
Filing Date
2025-01-22
Accepted
2025-01-22 16:06:21
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 lxrp_s3.htm S-3 183533
2 OPINION lxrp_ex51.htm EX-5.1 22882
3 CONSENT lxrp_ex231.htm EX-23.1 1453
4 FEE TABLE lxrp_ex107.htm EX-FILING FEES 40504
5 lxrp_ex51img1.jpg GRAPHIC 7086
6 lxrp_s3img1.jpg GRAPHIC 4786
7 lxrp_s3img2.jpg GRAPHIC 4786
  Complete submission text file 0001640334-25-000146.txt   272865
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: S-3 | Act: 33 | File No.: 333-284407 | Film No.: 25545978
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)